Skip to content

D89.832 ICD-10-CM Code: Cytokine release syndrome, grade 2

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

FY 2026 Apr update / Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) / Certain disorders involving the immune mechanism (D80-D89)

D89.832

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Cytokine release syndrome, grade 2

Cytokine release syndrome grade 2 is a moderate immune system reaction where the body releases excessive inflammatory chemicals (cytokines), typically occurring as a side effect of certain cancer treatments or immunotherapies. This grade involves moderate symptoms that may require medical intervention but are not immediately life-threatening.

CMS-HCC V28

0

0

RAF 0

CMS-HCC V24

0

0

RAF 0

ACA/HHS

0

0

RAF 0

ESRD/PACE

0

0

RAF 0

RXHCC

0

0

RAF 0

Code Trumping

Basket needed

Code Book Path

Official
D89.8Other specified disorders involving the immune mechanism, not elsewhere classified
D89.83Cytokine release syndrome
D89.832Cytokine release syndrome, grade 2

Inclusion Terms

Official

ICD-10-CM does not list inclusion terms for D89.832 in this effective period.

Excludes 2

Official

ICD-10-CM does not list Excludes 2 notes for D89.832 in this effective period.

Related Child Codes

Official
D89.831Cytokine release syndrome, grade 1
D89.833Cytokine release syndrome, grade 3
D89.834Cytokine release syndrome, grade 4
D89.835Cytokine release syndrome, grade 5
D89.839Cytokine release syndrome, grade unspecified

Includes

Official

ICD-10-CM does not list Includes notes for D89.832 in this effective period.

Excludes 1

Official

ICD-10-CM does not list Excludes 1 notes for D89.832 in this effective period.

Code First

Official
  • underlying cause, such as:
  • complications following infusion, transfusion and therapeutic injection (T80.89-)
  • complications of transplanted organs and tissue (T86.-)

Use Additional

Official
  • code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)

Code Also

Official

ICD-10-CM does not list Code Also instructions for D89.832 in this effective period.

Buddy Documentation Tip

HCC Buddy guidance
This code is commonly associated with CAR-T cell therapy, checkpoint inhibitors, and monoclonal antibody treatments—always verify the triggering medication or treatment in the clinical documentation
Grade 2 CRS requires careful distinction from grades 1, 3, and 4 as each has different severity levels and treatment implications; review clinical notes for symptom severity (fever, hypotension, organ dysfunction) to ensure correct grade assignment

Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.

Is D89.832 an HCC code?

No. D89.832 is a billable ICD-10-CM code but does not map to any HCC category in V28, V24, ESRD, or RxHCC.

Coder workflow notes

Get the V28 RAF + MEAT cheat sheet

One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.

Free PDF. No card. Unsubscribe anytime.

This code does not map to an HCC category in any model (V28, V24, ESRD, RxHCC).

What This Code Means

D89.832 is the ICD-10-CM diagnosis code for cytokine release syndrome, grade 2. Cytokine release syndrome grade 2 is a moderate immune system reaction where the body releases excessive inflammatory chemicals (cytokines), typically occurring as a side effect of certain cancer treatments or immunotherapies. This grade involves moderate symptoms that may require medical intervention but are not immediately life-threatening. D89.832 sits in the ICD-10-CM chapter for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (d50-d89), within the section covering certain disorders involving the immune mechanism (d80-d89).

D89.832 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.

This code is commonly associated with CAR-T cell therapy, checkpoint inhibitors, and monoclonal antibody treatments—always verify the triggering medication or treatment in the clinical documentation.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D89.832 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • This code is commonly associated with CAR-T cell therapy, checkpoint inhibitors, and monoclonal antibody treatments—always verify the triggering medication or treatment in the clinical documentation
  • Grade 2 CRS requires careful distinction from grades 1, 3, and 4 as each has different severity levels and treatment implications; review clinical notes for symptom severity (fever, hypotension, organ dysfunction) to ensure correct grade assignment

Child Codes

Code Hierarchy

Work D89.832 in HCC Buddy

Open D89.832 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 14 days to try everything.